117 related articles for article (PubMed ID: 15019560)
21. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
22. Facial emotion recognition deficit in amnestic mild cognitive impairment and Alzheimer disease.
Spoletini I; Marra C; Di Iulio F; Gianni W; Sancesario G; Giubilei F; Trequattrini A; Bria P; Caltagirone C; Spalletta G
Am J Geriatr Psychiatry; 2008 May; 16(5):389-98. PubMed ID: 18403572
[TBL] [Abstract][Full Text] [Related]
23. Alterations in regional brain volume and individual MRI-guided perfusion in normal control, stable mild cognitive impairment, and MCI-AD converter.
Wang H; Golob E; Bert A; Nie K; Chu Y; Dick MB; Mandelkern M; Su MY
J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):35-45. PubMed ID: 19150973
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Bouwman F; Venturelli E; Guidi I; Blankenstein MA; Bresolin N; Scarpini E
Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
[TBL] [Abstract][Full Text] [Related]
25. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
[TBL] [Abstract][Full Text] [Related]
26. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment.
Wang J; Markesbery WR; Lovell MA
J Neurochem; 2006 Feb; 96(3):825-32. PubMed ID: 16405502
[TBL] [Abstract][Full Text] [Related]
27. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.
Mauri M; Sinforiani E; Bono G; Cittadella R; Quattrone A; Boller F; Nappi G
Funct Neurol; 2006; 21(4):223-8. PubMed ID: 17367583
[TBL] [Abstract][Full Text] [Related]
28. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
[TBL] [Abstract][Full Text] [Related]
29. Neuropathologic substrate of mild cognitive impairment.
Markesbery WR; Schmitt FA; Kryscio RJ; Davis DG; Smith CD; Wekstein DR
Arch Neurol; 2006 Jan; 63(1):38-46. PubMed ID: 16401735
[TBL] [Abstract][Full Text] [Related]
30. Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study.
Franczak M; Prost RW; Antuono PG; Mark LP; Jones JL; Ulmer JL
J Comput Assist Tomogr; 2007; 31(5):666-70. PubMed ID: 17895774
[TBL] [Abstract][Full Text] [Related]
31. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
32. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
33. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
[TBL] [Abstract][Full Text] [Related]
34. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
Saka E; Dogan EA; Topcuoglu MA; Senol U; Balkan S
Arch Gerontol Geriatr; 2007; 44(2):141-51. PubMed ID: 16723158
[TBL] [Abstract][Full Text] [Related]
35. Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.
Urs R; Potter E; Barker W; Appel J; Loewenstein DA; Zhao W; Duara R
J Comput Assist Tomogr; 2009; 33(1):73-8. PubMed ID: 19188789
[TBL] [Abstract][Full Text] [Related]
36. Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects.
Weiss EM; Kohler CG; Vonbank J; Stadelmann E; Kemmler G; Hinterhuber H; Marksteiner J
Am J Geriatr Psychiatry; 2008 Dec; 16(12):974-80. PubMed ID: 19038896
[TBL] [Abstract][Full Text] [Related]
37. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
38. Hippocampal volume and cortical sources of EEG alpha rhythms in mild cognitive impairment and Alzheimer disease.
Babiloni C; Frisoni GB; Pievani M; Vecchio F; Lizio R; Buttiglione M; Geroldi C; Fracassi C; Eusebi F; Ferri R; Rossini PM
Neuroimage; 2009 Jan; 44(1):123-35. PubMed ID: 18805495
[TBL] [Abstract][Full Text] [Related]
39. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration.
Block W; Träber F; Flacke S; Jessen F; Pohl C; Schild H
Amino Acids; 2002; 23(1-3):317-23. PubMed ID: 12373553
[TBL] [Abstract][Full Text] [Related]
40. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment.
Bozzali M; Filippi M; Magnani G; Cercignani M; Franceschi M; Schiatti E; Castiglioni S; Mossini R; Falautano M; Scotti G; Comi G; Falini A
Neurology; 2006 Aug; 67(3):453-60. PubMed ID: 16894107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
